LIMA1 and metabolic dysfunction-associated steatohepatitis: This study explores the potential of serum sEV LIMA1 as a noninvasive biomarker for diagnosing MASH and delves into the role of LIMA1 in lipid accumulation in steatotic hepatocytes and MASLD progression.